Can we use drugs to modulate upper airway function in OSA?

L. Taranto Montemurro (Chestnut Hill , United States of America)

Source: International Congress 2018 – Sleep apnoea: is it time for new therapies?
Session: Sleep apnoea: is it time for new therapies?
Session type: Symposium
Number: 1911

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Taranto Montemurro (Chestnut Hill , United States of America). Can we use drugs to modulate upper airway function in OSA?. International Congress 2018 – Sleep apnoea: is it time for new therapies?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Synbiotics reduce airway inflammation and improve airway function in a mouse model for COPD
Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases
Year: 2012

Do standard clinical tests differentiate between asthma and upper airway dysfunction?
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation
Source: Eur Respir J 2016; 48: 1340-1350
Year: 2016



Dismantling airway disease with the use of new pulmonary function indices
Source: Eur Respir Rev, 28 (151) 180122; 10.1183/16000617.0122-2018
Year: 2019



Is lung clearance index a better marker of abnormal airway function than FEV1 in children with asthma?
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010

Loop gain as a determinant of upper airway stimulation efficacy in sleep apnoea
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019




Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy
Source: Annual Congress 2006 - New developments in the treatment and management of asthma
Year: 2006


Fluctuations in airway function: chronic asthma seen as a complex dynamic system
Source: Annual Congress 2006 - Physiological year in review
Year: 2006


The bronchodilator test in patients with chronic airway obstruction: the responsiveness of lung function parameters
Source: International Congress 2018 – Respiratory physiology and measurements
Year: 2018

Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design
Source: ERJ Open Res, 6 (2) 00333-2019; 10.1183/23120541.00333-2019
Year: 2020



The neural control of the upper airway in OSA
Source: ERS Conference
Year: 2015

Occlusion of the upper airway does not augment the cardiovascular response to arousal from sleep
Source: Eur Respir J 2004; 24: Suppl. 48, 329s
Year: 2004

Failure of upper airway dilator muscle activation to restore pharyngeal patency in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2008 - Pathogenesis of obstructive sleep apnoea
Year: 2008



Physical activity, airway resistance and small airway dysfunction in severe asthma
Source: Eur Respir J 2017; 49(1): 1601827; DOI: 10.1183/13993003.01827-2016
Year: 2017


The ability of fluctuation analysis of airway function and symptoms to asses asthma stability in different asthma phenotypes
Source: Eur Respir J 2007; 30: Suppl. 51, 257s
Year: 2007

The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and quality of life in patients with asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016